Loading...
XJPX
4574
Market cap83mUSD
Jul 10, Last price  
269.00JPY
1D
-0.37%
1Q
-9.43%
Jan 2017
-56.45%
IPO
-3.16%
Name

Taiko Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XJPX:4574 chart
P/E
14.65
P/S
2.11
EPS
18.37
Div Yield, %
Shrs. gr., 5y
2.99%
Rev. gr., 5y
-18.40%
Revenues
6.40b
+1.67%
4,935,000,0005,542,120,0006,091,323,0008,733,433,0004,470,424,0006,690,812,0007,415,743,0009,868,287,0009,237,774,0008,295,288,0008,284,887,0009,438,366,00010,377,646,00014,936,165,00017,683,989,00010,720,000,0005,040,000,0006,120,000,0006,292,000,0006,397,000,000
Net income
923m
+2.78%
379,000,000360,439,000470,777,0001,645,122,000-2,228,208,000482,204,0001,037,525,0001,747,233,0001,770,541,000840,110,0001,049,416,0001,094,959,0001,415,491,0002,453,466,0003,851,559,000-9,593,000,000-4,894,000,000-3,611,000,000898,000,000923,000,000
CFO
814m
+124.86%
261,820,0001,137,859,0001,896,241,000-1,690,234,000533,965,0001,092,906,0003,589,419,000690,381,000377,676,0002,697,614,000-59,647,0001,748,182,0003,493,291,000-1,516,902,000-1,595,000,000-1,994,000,000-307,000,000362,000,000814,000,000
Dividend
Dec 29, 20263.5 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
IPO date
Mar 18, 2009
Employees
210
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT